Digital Medicine Society (DiMe) announced today that it was partnering with Peterson Health Technology Institute (PHTI), ZS Associates, and other leading industry organizations in order to define how integrated evidence plans (IEPs) can be developed, optimized, and used to support the regulatory and commercial success of digital health products (DHPs) on an accelerated timeline.. The goal of the project is to streamline the pathways to successful commercialization of high-value, evidence-based DHPs in response to the top priority identified by industry leaders in DiMe's recent Digital Health Industry Regulatory Needs Assessment: to align regulatory requirements and decision-making with downstream payers and purchasers, with the goal of aligning best practices between regulatory requirements and decision-making.
The goal of the project is to streamline the pathways to successful commercialization of high-value, evidence-based DHPs in response to the top priority identified by industry leaders in DiMe's recent Digital Health Industry Regulatory Needs Assessment: to align regulatory requirements and decision-making with downstream payers and purchasers, with the goal of aligning best practices between regulatory requirements and decision-making.
As the business landscape continues to evolve and mature, it is important to address the challenges that are arising from the lack of evidence surrounding DHPs today. This latest project from DiMe will address these obstacles to help streamline the path to broad adoption of evidence-based digital health technologies, build confidence with digital health purchasing organizations, and optimize health outcomes for the greatest number of patients – all while advancing innovation in the digital health landscape. 

Source prnewswire